Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors

Zhou, 2020, Biomimetic nanotechnology toward personalized vaccines, Adv. Mater., 32 Islam, 2021, Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice, Biomaterials, 266, 10.1016/j.biomaterials.2020.120431 Li, 2018, A facile approach to enhance antigen response for personalized cancer vaccination, Nat. Mater., 17, 528, 10.1038/s41563-018-0028-2 Liu, 2014, Structure-based programming of lymph-node targeting in molecular vaccines, Nature, 507, 519, 10.1038/nature12978 Moon, 2011, Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses, Nat. Mater., 10, 243, 10.1038/nmat2960 Beatty, 2015, Immune escape mechanisms as a guide for cancer immunotherapy, Clin. Cancer Res., 21, 687, 10.1158/1078-0432.CCR-14-1860 Ekdawi, 2016, Nanomedicine and tumor heterogeneity: concept and complex reality, Nano Today, 11, 402, 10.1016/j.nantod.2016.06.006 De Palma, 2017, Microenvironmental regulation of tumour angiogenesis, Nat. Rev. Cancer, 17, 457, 10.1038/nrc.2017.51 Ding, 2018, Large‐pore mesoporous‐silica‐coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy, Adv. Mater., 30, 10.1002/adma.201802479 Li, 2020, Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells, Nat. Biomed. Eng., 4, 1102, 10.1038/s41551-020-0599-5 Patel, 2019, Development of an in situ cancer vaccine via combinational radiation and bacterial‐membrane‐coated nanoparticles, Adv. Mater., 31, 10.1002/adma.201902626 Keenan, 2012, Whole cell vaccines—past progress and future strategies, Semin. Oncol., 39, 276, 10.1053/j.seminoncol.2012.02.007 Chu, 2014, Thermal ablation of tumours: biological mechanisms and advances in therapy, Nat. Rev. Cancer, 14, 199, 10.1038/nrc3672 Li, 2020, Clinical development and potential of photothermal and photodynamic therapies for cancer, Nat. Rev. Clin. Oncol., 17, 657, 10.1038/s41571-020-0410-2 Peng, 2018, Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy, Adv. Sci., 5 Ji, 2021, A nano vector with photothermally enhanced drug release and retention to overcome cancer multidrug resistance, Nano Today, 36, 10.1016/j.nantod.2020.101020 Huang, 2019, Completion of the cytosolic post-chorismate phenylalanine biosynthetic pathway in plants, Nat. Commun., 10, 15, 10.1038/s41467-018-07969-2 Ishikawa, 2008, STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling, Nature, 455, 674, 10.1038/nature07317 Gui, 2019, Autophagy induction via STING trafficking is a primordial function of the cGAS pathway, Nature, 567, 262, 10.1038/s41586-019-1006-9 Shae, 2020, Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines, ACS Nano, 14, 9904, 10.1021/acsnano.0c02765 Miao, 2019, Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation, Nat. Biotechnol., 37, 1174, 10.1038/s41587-019-0247-3 Zhou, 2020, Engineering polymeric prodrug nanoplatform for vaccination immunotherapy of cancer, Nano Lett., 20, 4393, 10.1021/acs.nanolett.0c01140 Luo, 2017, A STING-activating nanovaccine for cancer immunotherapy, Nat. Nanotechnol., 12, 648, 10.1038/nnano.2017.52 Shae, 2019, Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy, Nat. Nanotechnol., 14, 269, 10.1038/s41565-018-0342-5 Lv, 2020, Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy, Cell Res., 30, 966, 10.1038/s41422-020-00395-4 Wang, 2018, Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses, Immunity, 48, 675, 10.1016/j.immuni.2018.03.017 Hou, 2020, Manganese-based nanoactivator optimizes cancer immunotherapyviaenhancing innate immunity, ACS Nano, 14, 3927, 10.1021/acsnano.9b06111 Hooy, 2020, Allosteric coupling between Mn2+ and dsDNA controls the catalytic efficiency and fidelity of cGAS, Nucleic Acids Res., 48, 4435, 10.1093/nar/gkaa084 Zhao, 2020, Mn2+ directly activates cGAS and structural analysis suggests Mn2+ induces a noncanonical catalytic synthesis of 2′3′-cGAMP, Cell Rep., 32, 10.1016/j.celrep.2020.108053 Song, 2020, Cell. Mol. Immunol. Zhang, 2019, Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating T cells and potentiates anti-PD-1 therapy, Nano Lett., 19, 2774, 10.1021/acs.nanolett.8b04296 Pilon-Thomas, 2016, Neutralization of tumor acidity improves antitumor responses to immunotherapy, Cancer Res., 76, 1381, 10.1158/0008-5472.CAN-15-1743 Huber, 2017, Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation, Semin. Cancer Biol., 43, 74, 10.1016/j.semcancer.2017.03.001 Prasad, 2014, ACS Nano, 8, 6510, 10.1021/nn502569e Song, 2016, Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia, ACS Nano, 10, 633, 10.1021/acsnano.5b06779 Kroll, 2017, Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity, Adv. Mater., 29, 10.1002/adma.201703969 Fang, 2018, Cell membrane coating nanotechnology, Adv. Mater., 30, 10.1002/adma.201706759 Fang, 2014, Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, Nano Lett., 14, 2181, 10.1021/nl500618u Jo, 2017, Harnessing designed nanoparticles: current strategies and future perspectives in cancer immunotherapy, Nano Today, 17, 23, 10.1016/j.nantod.2017.10.008 Sweeney, 2018, Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma, Small, 14, 10.1002/smll.201800678 Apetoh, 2007, Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat. Med., 13, 1050, 10.1038/nm1622 Obeid, 2007, Calreticulin exposure dictates the immunogenicity of cancer cell death, Nat. Med., 13, 54, 10.1038/nm1523 Obeid, 2007, Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis, Cell Death Differ., 14, 1848, 10.1038/sj.cdd.4402201 Song, 2018, Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer, Nano Lett., 18, 6360, 10.1021/acs.nanolett.8b02720 Yang, 2019, Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors, Nano Lett., 19, 4334, 10.1021/acs.nanolett.9b00934 Sun, 2010, Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A2, Cell. Mol. Immunol., 7, 77, 10.1038/cmi.2009.105 Platzer, 2015, IgE/FcεRI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses, Cell Rep., 10, 1487, 10.1016/j.celrep.2015.02.015 Li, 2020, Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy, Sci. Adv., 6, eaaz9240, 10.1126/sciadv.aaz9240 Sakaguchi, 2010, FOXP3+ regulatory T cells in the human immune system, Nat. Rev. Immunol., 10, 490, 10.1038/nri2785 Kong, 2021, Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications, Nano Today, 36, 10.1016/j.nantod.2020.101004 Feng, 2020, Germanene-based theranostic materials for surgical adjuvant treatment: inhibiting tumor recurrence and wound infection, Matter, 3, 127, 10.1016/j.matt.2020.04.022 Feng, 2019, Self‐amplified drug delivery with light‐inducible nanocargoes to enhance cancer immunotherapy, Adv. Mater., 31, 10.1002/adma.201902960